-----BEGIN PRIVACY-ENHANCED MESSAGE----- Proc-Type: 2001,MIC-CLEAR Originator-Name: webmaster@www.sec.gov Originator-Key-Asymmetric: MFgwCgYEVQgBAQICAf8DSgAwRwJAW2sNKK9AVtBzYZmr6aGjlWyK3XmZv3dTINen TWSM7vrzLADbmYQaionwg5sDW3P6oaM5D3tdezXMm7z1T+B+twIDAQAB MIC-Info: RSA-MD5,RSA, WqtktRVYq4XuXH7E1ICFqY1IgiY9uTEkyg4FCVBF3akKl062mCM+0v5iMRSUpZao tPviZ+/dA4hJAkaIQZJwqw== 0001213900-10-001351.txt : 20100409 0001213900-10-001351.hdr.sgml : 20100409 20100409151512 ACCESSION NUMBER: 0001213900-10-001351 CONFORMED SUBMISSION TYPE: 10-Q PUBLIC DOCUMENT COUNT: 5 CONFORMED PERIOD OF REPORT: 20100228 FILED AS OF DATE: 20100409 DATE AS OF CHANGE: 20100409 FILER: COMPANY DATA: COMPANY CONFORMED NAME: MAXLIFE FUND CORP. CENTRAL INDEX KEY: 0001379377 STANDARD INDUSTRIAL CLASSIFICATION: FINANCE SERVICES [6199] IRS NUMBER: 000000000 STATE OF INCORPORATION: WY FISCAL YEAR END: 0831 FILING VALUES: FORM TYPE: 10-Q SEC ACT: 1934 Act SEC FILE NUMBER: 333-138298 FILM NUMBER: 10742474 BUSINESS ADDRESS: STREET 1: 2788 BATHURST STREET STREET 2: SUITE 306 CITY: TORONTO STATE: A6 ZIP: M6B 3A3 BUSINESS PHONE: 416-200-0657 MAIL ADDRESS: STREET 1: 2788 BATHURST STREET STREET 2: SUITE 306 CITY: TORONTO STATE: A6 ZIP: M6B 3A3 10-Q 1 f10q0210_maxlife.htm QUARTERLY REPORT f10q0210_maxlife.htm
 



UNITED STATES
SECURITIES AND EXCHANGE COMMISSION
WASHINGTON, D.C. 20549
_______________
 
FORM 10-Q
_______________
 
x QUARTERLY REPORT PURSUANT TO SECTION 13 OR 15(d) OF THE SECURITIES EXCHANGE ACT OF 1934
 
For the quarterly period ended February 28, 2010
 
o TRANSITION REPORT PURSUANT TO SECTION 13 OR 15(d) OF THE SECURITIES EXCHANGE ACT OF 1934

 For the transition period from ______to______.
 
MAXLIFE FUND CORP.
 (Exact name of registrant as specified in charter)
 
WYOMING
 
333-138298
   
(State or other jurisdiction of
incorporation or organization)
 
(Commission File No.)
 
(IRS Employee Identification No.)

45 Sheppard Avenue East, Suite 900
North York, Ontario, Canada M2N 5W9
 (Address of principal executive offices)
 _______________
 
1-866-752-5557
 (Registrant’s telephone number, including area code)
_______________
 
Indicate by check mark whether the registrant (1) has filed all reports required to be filed by Section 13 or 15(d) of the Securities Exchange Act of 1934 during the preceding 12 months (or for such shorter period that the registrant was required to file such reports), and (2) has been subject to such filing requirements for the past 90 days.          Yes x No o
 
Indicate by check mark whether the registrant has submitted electronically and posted on its corporate Web site, if any, every Interactive Data File required to be submitted and posted pursuant to Rule 405 of Regulation S-T (§232.405 of this chapter) during the preceding 12 months (or for such shorter period that the registrant was required to submit and post such files).           Yes o No o

Indicate by check mark whether the registrant is a large accelerated filer, an accelerated filer, a non-accelerated filer or a smaller reporting company filer.  See definition of “accelerated filer” and “large accelerated filer” in Rule 12b-2 of the Exchange Act (Check one):
 
Large Accelerated Filer o                                                                                                     Accelerated Filer x  
  
Non-Accelerated Filer o                                                                                                    Smaller Reporting Company o
 
Indicate by check mark whether the registrant is a shell company as defined in Rule 12b-2 of the Exchange Act. Yes  No 

As of April 9, 2010, there were 16,253,168 shares outstanding of the registrant’s common stock.
 


 


MAXLIFE FUND CORP.
 
FORM 10-Q
 
February 28, 2010
 
INDEX
 
 

PART I – FINANCIAL INFORMATION  1
     
Item 1.
Financial Statements
  1
Item 2.
Management’s Discussion and Analysis of Financial Condition
  2
Item 3.
Quantitative and Qualitative Disclosures About Market Risk
  11
Item 4T
Control and Procedures
  12
     
PART II – OTHER INFORMATION  13
     
 Item 1
Legal Proceedings
  13
 Item 1A.
Risk Factors
  13
 Item 2.
Unregistered Sales of Equity Securities and Use of Proceeds
  13
 Item 3.
Defaults Upon Senior Securities
  13
 Item 4.
(Removed and Reserved)
  13
 Item 5.
Other Information
  13
 Item 6.
Exhibits
  13
     
SIGNATURE  14
 


 
 
PART I – FINANCIAL INFORMATION

Item 1.  Financial Statements








MAXLIFE FUND CORP. AND SUBSIDIARY
(A Development Stage Company)
 
CONSOLIDATED FINANCIAL STATEMENTS
 
28 FEBRUARY 2010
 
 
 
 
 
 
 

 

 
MAXLIFE FUND CORP. AND SUBSIDIARY
 
(A Development Stage Company)
 
CONSOLIDATED BALANCE SHEETS
 
AS AT
 
(Expressed in United States Dollars)
 
   
28 February 
2010
(Unaudited)
   
31 August
2009
(Audited)
 
ASSETS
           
             
Current Assets
           
Cash
  $ -     $ 48,917  
Available-for-sale securities, at fair value (cost - $24,638, 31 August 2009 - $24,638)
    90       136  
Total Current Assets
    90       49,053  
                 
Long Term Assets
               
Investment in life insurance policies
    557,695       533,307  
Total Assets
  $ 557,785     $ 582,360  
                 
LIABILITIES AND STOCKHOLDERS’ EQUITY
               
                 
Current Liabilities
               
Bank indebtedness
  $ 20,917     $ -  
Accounts payable and accrued liabilities
    67,720       23,072  
Management salary payable
    217,400       150,000  
Advances from stockholder
    3,780       3,813  
Dividends payable on preferred stock
    33,000       -  
Total Liabilities
    342,817       176,885  
                 
Stockholders’ Equity
               
Preferred stock $25.00 par value; Authorized 100,000,000; Issued and outstanding 26,400  (31 August 2009 - 26,400); non-voting; dividends of $0.625 paid on a quarterly basis; non-convertible; redeemable at the option of the Company after two years
    660,000       660,000  
Common stock $.001 par value; Authorized 200,000,000; Issued and outstanding 16,253,168  (31 August 2009 - 16,253,168)
    16,253       16,253  
Additional paid-in capital
    1,100,626       1,100,626  
Additional paid in capital - warrants
    244,158       244,158  
Accumulated other comprehensive loss
    (41,095 )     (41,061 )
Deficit accumulated during the development stage
    (1,764,974 )     (1,574,501 )
Total Stockholders’ Equity
    214,968       405,475  
Total Liabilities and Stockholders’ Equity
  $ 557,785     $ 582,360  
 
 
The accompanying notes are an integral part of these financial statements.
-2-

 
 
MAXLIFE FUND CORP. AND SUBSIDIARY
 
(A Development Stage Company)
 
CONSOLIDATED STATEMENTS OF OPERATIONS AND COMPREHENSIVE LOSS
 
(Expressed in United States Dollars)
            (Unaudited)
 
   
For the Three
Months Ended
28 Feb 2010
   
For the Three
Months Ended
28 Feb 2009
 
SALE OF POLICY
    -       -  
COST OF POLICY SOLD
    -       -  
GROSS PROFIT
    -       -  
EXPENSES
               
Management salaries
    37,500       36,502  
Interest and bank charges
    538       84  
General and administrative
    5,607       48,772  
Professional fees
    10,063       52,305  
Gain on foreign exchange
    (2,313 )     (17,667 )
TOTAL OPERATING EXPENSES
    51,395       119,996  
LOSS FROM OPERATIONS
    (51,395 )     (119,996 )
INTEREST INCOME
    486       428  
NET LOSS
  $ (50,909 )   $ (119,568 )
FOREIGN CURRENCY TRANSLATION ADJUSTMENT
    (2,033 )     (17,610 )
UNREALIZED LOSS ON AVAILABLE-FOR-SALE SECURITIES
    -       (1,302 )
COMPREHENSIVE LOSS
    (52,942 )     (138,480 )
LOSS PER WEIGHTED NUMBER OF SHARES OUTSTANDING - BASIC AND DILUTED
    0.00       0.00  
WEIGHTED AVERAGE NUMBER OF SHARES OUTSTANDING - BASIC AND DILUTED
    16,253,168       30,303,168  
 
 
The accompanying notes are an integral part of these financial statements.
-3-

 
MAXLIFE FUND CORP. AND SUBSIDIARY
 
(A Development Stage Company)
 

 
CONSOLIDATED STATEMENTS OF OPERATIONS AND COMPREHENSIVE LOSS
 
(Expressed in United States Dollars)
                                                                                                     (Unaudited)
 
   
For the Six
Months Ended
28 February
2010
   
For the Six
Months Ended
28 February
2009
   
For the
Period from Inception
(9 January 2006) to
28 February
 2010
 
SALE OF POLICY
    -       -       330,000  
COST OF POLICY SOLD
    -       -       303,250  
GROSS PROFIT
    -       -       26,750  
                         
EXPENSES
                       
Management salaries
    75,000       66,502       246,578  
Professional fees
    65,603       103,698       392,934  
General and administrative
    20,083       53,128       257,499  
Interest and bank charges
    1,052       220       4,157  
Stock based compensation
    -       124,610       487,780  
Gain on foreign exchange
    (3,266 )     (13,582 )     (2,857 )
TOTAL OPERATING EXPENSES
    158,472       334,576       1,386,091  
LOSS FROM OPERATIONS
    (158,472 )     (334,576 )     (1,359,341 )
REALIZED LOSS ON SALE OF AVAILABLE-FOR-SALE SECURITIES
    -               (16,474 )
GOODWILL IMPAIRMENT LOSS
    -       -       (35,269 )
LOSS ON INVESTMENT IN JOINT VENTURE
    -       -       (1,250 )
INTEREST INCOME
    1,000       1,171       7,020  
NET LOSS
  $ (157,472 )   $ (333,405 )   $ (1,405,314 )
FOREIGN CURRENCY TRANSLATION ADJUSTMENT
    (34 )     (16,156 )     (16,593 )
UNREALIZED LOSS ON AVAILABLE-FOR-SALE SECURITIES
    -       (7,220 )     (24,502 )
COMPREHENSIVE LOSS
  $ (157,506 )     (356,781 )     (1,446,409 )
LOSS PER WEIGHTED NUMBER OF SHARES OUTSTANDING - BASIC AND DILUTED
  $ (0.01 )   $ (0.01 )        
WEIGHTED AVERAGE NUMBER OF SHARES OUTSTANDING - BASIC AND DILUTED
    16,253,168       30,303,168          

 
The accompanying notes are an integral part of these financial statements.
-4-

 
MAXLIFE FUND CORP. AND SUBSIDIARY
 
(A Development Stage Company)
 
CONSOLIDATED STATEMENTS OF CASH FLOWS
 
(Expressed in United States Dollars)
         (Unaudited)
 
   
For the Six
Months Ended
28 February
2010
   
For the Six
Months Ended
28 February
2009
   
For the  Period from Inception
(9 January
2006) to
28 February
2010
 
CASH FLOWS FROM OPERATING ACTIVITIES
                 
Net loss
  $ (157,472 )   $ (333,405 )   $ (1,405,314 )
Adjustments to reconcile net loss to net cash used in operating activities:
                       
Goodwill impairment loss
    -       -       35,269  
Stock based compensation
    -       124,609       453,580  
Unrealized loss on available-for-sale securities
    -       (7,220 )     (88,318 )
Dividends payable on preferred stock
    -       -       33,000  
Equity issued to acquire 1255450 Ontario Limited
    -       -       5,000  
Issuance of common stock for services
    -       -       75,200  
Loss on investment in joint venture
    -       -       1,250  
Realization of loss on available for sale securities
    -       -       57,973  
Changes in operating assets and liabilities:
                       
Available-for-sale securities
    46       1,913       (90 )
Proceeds on sale of policy
    -       -       330,000  
Purchase of insurance policies and capitalized premiums
    (24,423 )     (50,942 )     (864,703 )
Accounts payable and accrued liabilities
    44,682       1,228       62,787  
Management salary payable
    67,400       45,000       217,400  
CASH USED IN OPERATING ACTIVITIES
    (69,767 )     (218,817 )     (1,086,966 )
CASH FLOWS FROM INVESTING ACTIVITIES
                       
Capital contribution  -  joint venture
    -       -       (1,250 )
Acquisition of 1255450 Ontario Limited
    -       -       (21,739 )
CASH FLOWS USED IN INVESTING ACTIVITIES
    -       -       (22,989 )
CASH FLOWS FROM FINANCING ACTIVITIES
                       
Proceeds from bank indebtedness
    20,917       -       20,917  
Issuance of preferred stock
    -       -       660,000  
Advances to stockholder
    (33 )     (763 )     (27,813 )
Dividends paid
    -       (33,000 )     (115,500 )
Financing fees
    -       -       (8,000 )
Issuance of common stock
    -       -       591,100  
CASH FLOWS PROVIDED BY (USED IN) FINANCING ACTIVITIES
    20,884       (33,763 )     1,120,704  
EFFECT OF FOREIGN CURRENCY TRANSLATION
    (34 )     (16,156 )     (10,749 )
NET DECREASE IN CASH
    (48,917 )     (268,736 )     -  
CASH, BEGINNING OF YEAR
    48,917       500,836       -  
CASH, END OF YEAR
  $ -     $ 232,100     $ -  

The accompanying notes are an integral part of these financial statements.
-5-


 

1.
NATURE OF OPERATIONS

MaxLife Fund Corp, Inc. (the “Company”) was incorporated on 9 January 2006 under the laws of the State of Wyoming.
 
The Company is concentrating on three major components of the Life Settlement sector (i) to generate fee income by providing a turnkey investment solution for accredited investors wanting to own life insurance policies, (ii) to obtain ownership in companies in the life settlement industry and (iii) to build a large portfolio for institutional buyers and be involved as an intermediary. MaxLife is positioning itself to grow with the industry and expand its operation to become one of the leaders in the Life Settlement sector.

2.
BASIS OF PRESENTATION

The accompanying unaudited interim financial statements have been prepared in accordance with accounting principles generally accepted in the United States of America for interim financial information and the SEC instructions to Form 10-Q. Accordingly, they do not include all of the information and footnotes required by generally accepted accounting principles for complete financial statements. In the opinion of management, all adjustments (consisting of normal recurring accruals) considered necessary for a fair presentation have been included.  Operating results for the three month period ended 28 February 2010 are not necessarily indicative of the results that may be expected for the year ending 31 August 2010.  For further information, refer to the financial statements and footnotes thereto included in the Company’s annual report on Form 10-K for the year ended 31 August 2009.

Recent Accounting Pronouncements

In June 2009 the Financial Accounting Standards Board (“FASB”) issued statement No. 168, The FASB Accounting Standards Codification and The Hierarchy of Generally Accepted Accounting Principles. The Codification became the source of authoritative generally accepted accounting principles (“GAAP”) recognized by the FASB to be applied by nongovernmental entities. Rules and interpretive releases of the SEC under authority of federal securities laws are also sources of authoritative GAAP for SEC registrants. The Codification supersedes all existing non-SEC accounting and reporting standards. All other nongrandfathered non-SEC accounting literature not included in the Codification is nonauthoritative. GAAP is not intended to be changed as a result of this statement, but will change the way the guidance is organized and presented. During the current quarter, the Company has implemented the Codification in the consolidated financial statements by providing references to the Accounting Standards Codification (“ASC”) topics.

In January 2010, the FASB issued Accounting Standards Update 2010-06, or ASU No. 10-06, Fair Value Measurements and Disclosures (Topic 820) – Improving Disclosures about Fair Value Measurements. ASU No. 10-06 requires an entity to disclose separately the amounts of significant transfers in and out of Level 1 and 2 fair value measurements, and describe the reasons for the transfers. Also, it requires additional disclosure regarding purchases, sales, issuances and settlements of Level 3 measurements. ASU No. 10-06 is effective for interim and annual periods beginning after December 15, 2009, except for the additional disclosure of Level 3 measurements, which is effective for fiscal years beginning after December 15, 2010. The Company does not expect the adoption of this statement to have a material impact on its consolidated financial statements.

3.
INVESTMENT IN INSURANCE POLICIES

As at 28 February 2010 the Company holds four life insurance policies with carrying amounts of $557,695 and face amounts totaling $2,650,000.

4.
ADVANCES FROM STOCKHOLDER

The advances from the stockholder are non-interest bearing, unsecured and are due on demand.  The carrying value of the advances approximates the market value due to the short-term maturity of the financial instruments.
 
-6-

 

 
5.
PREFERRED STOCK

During the quarter ended 28 February 2010 the company declared dividends on its 26,400 (31 August 2009 - 26,400) issued and outstanding preferred stock totaling $16,500 (31 August 2009 - $66,000).

6.
COMMITMENT AND CONTINGENT LIABILITY

The Company is contingently liable for the payment of the premiums due on the insurance policies as described in Note 3.  Although the individual beneficiary is responsible for these payments, if they are not paid when they fall due, the Company must pay these premiums on the insured’s behalf within a 30 day grace period or the policy would lapse.  As of 28 February 2010, the policies premiums were up to date and the policies were in good standing.

7.
FINANCIAL INSTRUMENTS

The carrying value of the Company’s cash, accounts payable and accrued liabilities, management salary payable and advances from stockholder approximates fair value because of the short term maturity of these instruments.
 
 
 
-7-

 
Item 2. Management’s Discussion and Analysis of Financial Condition and Plan of Operations.

Certain statements contained in this quarterly filing, including, without limitation, statements containing the words “believes,” “anticipates,” “expects” and words of similar import, constitute forward-looking statements. Such forward-looking statements involve known and unknown risks, uncertainties and other factors that may cause the actual results, performance or achievements of the Company, or industry results, to be materially different from any future results, performance or achievements expressed or implied by such forward-looking statements.

Such factors include, among others, the following: international, national and local general economic and market conditions; demographic changes; the ability of the Company to sustain, manage or forecast its growth; the ability of the Company to successfully make and integrate acquisitions; raw material costs and availability; new product development and introduction; existing government regulations and changes in, or the failure to comply with government regulations; adverse publicity; competition; the loss of significant customers or suppliers; fluctuations and difficulty in forecasting operating results; changes in business strategy or development plans; business disruptions; the ability to attract and retain qualified personnel; the ability to protect technology; and other factors referenced in this and previous filings.  Given these uncertainties, readers of this prospectus and investors are cautioned not to place undue reliance on such forward-looking statements.
 
Plan of Operations
 
During the next twelve months, we expect to take the following steps in connection with the further development of our business and the implementation of our plan of operations: 

We will continue to make relationships with insurance brokers and their clients to seek out opportunistic policies and life settlements.  We will attempt to raise additional financing for working capital and marketing efforts.  We will also seek investment partners in order to raise the necessary funds to acquire existing policies on behalf of clients and partners. Such partners include banks, hedge funds, investment funds and sophisticated investors.  We will be sourcing new relationships with companies in the sector with the objective of purchasing an ownership in their businesses. Many opportunities are arising as the market place is seeing distress situations of Hedge Funds that need to liquidate life settlement policies and portfolios due to the ongoing financial crisis. MaxLife will review such situations and is open to discussions to determine the opportunities that can be cultivated accordingly.

We have shifted our business structure toward a business model which focuses on acquisition or funding of life policies of individuals on behalf of strategic buyers.  MaxLife is looking to generate fees by facilitating such transactions. We are no longer looking to purchase or fund life policies of individuals for our own inventory. Further, our goal is to earn fees by administering a large number of policies on behalf of clients and funds and earning a management and performance fee. In this regard, the current inventory of life settlement policies that MaxLife owns will also be put up for sale and MaxLife will maintain a performance fee as to future occurrences with such policies.

We will prepare advertisements and information material to disseminate to our network of brokers with the intention of ramping up purchases of policies for clients and partners.  With funds obtained from banks and investment funds we will be in a position to purchase and administer policies and portfolios on their behalf and thereby earn fees for administration and profit participation.  We will also look to offer a product which gives investors the security they require in these times and we will charge for our expertise and services of sourcing, buying, and monitoring their investments.

The addition of a stronger infrastructure will be required and we intend to hire management personnel and support staff.  This will enable us to segregate work responsibilities and meet the ongoing growth of the business.  We will be in a position to handle different territories both in Canada and the United States.
 
Additional financings will be available to us through our relationships and performance.  This will enable us to continue with our growth plans.  The internal organization will be reviewed to see that it can handle the influx of new business.  The administration of the policies will be pertinent and we will have to determine if we have sufficient staff to handle this responsibility.
 
 
-8-


 
The management team will be strengthened, if need be, to ensure that shareholder value is maximized and the business plan is being implemented properly.

During the three months ended February 28, 2010, MaxLife has made a concentrated effort to bring to market a financial product that is based on life settlement policies with maximum life expectancies of five (5) years.  Investors open a trust that is administered with the assistance of MaxLife. The investor can earn good returns on their trust that own the life settlement policies over the five (5) year program period.  Downside protection is available through a commitment from MaxLife and/or from outside companies. The product description and information is available on the website (www.themxway.com) and by contacting the Company.

MaxLife has travelled to countries and met with pension funds, hedge funds, insurance companies and accredited investor groups that have been apprised of the life settlement industry and the MX-Series product has been made available to them as a turnkey investment opportunity.

We will continue to focus on these groups that we met during the past year and will pursue new opportunities by making inroads with wealth management groups in additional countries as well.
 
Results of Operations

Comparative Analysis for the six months ended February 28, 2010 and 2009:

General and administrative expenses for the six months ended February 28, 2010 were $20,083 and $53,128 for the six months ended February 28, 2009.  The decrease during the six months ended February 28, 2010, was primarily attributable to decreases in payments for travel, administrative office expenses, and directors and officers insurance incurred in the business operations.

Professional fees for the six months ended February 28, 2010 were $65,603 and $103,698 for the six months ended February 28, 2009.  These fees are attributable to legal, accounting, tax, consulting and auditing services. The decrease in professional fees was attributable to the decrease in consulting, tax, and accounting fees during the six months ended February 28, 2010.
  
Stock based compensation for the six months ended February 28, 2010 were $0 and $124,610 for the six months ended February 28, 2009.  The decrease in stock based compensation was due to a reduced residual balance for amortization of stock options which commenced in April 2008.

For the six months ended February 28, 2010, we had a net loss of $157,472 and net loss of $333,405 for the six months ended February 28, 2009.   The decrease in operating expenses during the six months ended February 28, 2010, was due to lower general and administrative expenses, professional fees and stock based compensation expenses during the period.

During the six months ended February 28, 2010, and six months ended February 28, 2009, we had no provision for income taxes due to the net operating losses incurred.

Capital Resources and Liquidity

We are still in the process of developing and implementing our business plan and raising additional capital. As such, management is taking action to obtain additional funding.

At February 28, 2010, we had negative working capital of approximately $342,727. It is the intent of management and significant stockholders, if necessary, to provide sufficient working capital necessary to support and preserve the integrity of the corporate entity. However, there is no legal obligation for either management or significant stockholders to provide additional future funding. We have implemented a preferred share unit offering consisting of preferred shares and warrants. The unit offering will be continued to be offered in order to obtain the financing we require.
 
-9-

 

 
On March 22, 2010, MaxLife entered into three agreements to sell a 50% interest in three life settlement policies in which the Company is the owner. The purchase price is for a total of $275,000 of which a 10% deposit was received. The agreement states that the purchaser (a private entity, non affiliated with MaxLife), will take ownership of the policies and MaxLife will retain a 50% interest in the policies. MaxLife will be responsible to pay 50% of premium costs in regards to these policies. The funds from the sale of these policies will further enable the Company to be properly fund and carry forth its business plan and plan of operations. The sale of these policies will provide additional working capital requirements to the Company and will assist in developing and implementing its business plan.

Additional financing is available to the Company through the private placement of preferred share issuances to new and existing investors and shareholders. The Company has developed a financial product, MX-Series and strongly believes revenues will be generated within the next few quarters which will be utilized to support its plan of operations and future growth plans.
 
Cash flows from operating activities

Cash flows used in operating activities for the six months ended February 28, 2010, were $69,767 and $218,817 for the six months ended February 28, 2009.  The decrease in cash flows used in operating activities was primarily due to an increase in accounts payable during the six months ended February 28, 2010, and decreases in general and administrative and professional fees.

Cash flows from investing activities

There were no cash flows used in investing activities for the six months ended February 28, 2010, and for the six months ended February 28, 2009.  

Cash flows from financing activities

During the six months ended February 28, 2010, the Company declared quarterly dividends of $0.625 per share annually on its 26,400 issued and outstanding preferred stock totaling $33,000. During the six months ended February 28, 2009, the Company declared quarterly dividends of $0.625 per share annually on its 26,400 issued and outstanding preferred stock totaling $33,000.

MaxLife is also reviewing other financing options as lines of credits or asset based loans to coincide with the equity raised.
 
Critical Accounting Policies
 
Max Life’s financial statements and related public financial information are based on the application of accounting principles generally accepted in the United States (“GAAP”). GAAP requires the use of estimates; assumptions, judgments and subjective interpretations of accounting principles that have an impact on the assets, liabilities, revenue and expense amounts reported. These estimates can also affect supplemental information contained in our external disclosures including information regarding contingencies, risk and financial condition. We believe our use of estimates and underlying accounting assumptions adhere to GAAP and are consistently and conservatively applied. We base our estimates on historical experience and on various other assumptions that we believe to be reasonable under the circumstances. Actual results may differ materially from these estimates under different assumptions or conditions. We continue to monitor significant estimates made during the preparation of our financial statements.
 
Refer to Note 2 of our August 31, 2009, audited financial statements (as filed with the SEC on Form 10-K on November 30, 2009), which summarizes our significant accounting policies. While all these significant accounting policies impact its financial condition and results of operations, MaxLife views certain of these policies as critical. Policies determined to be critical are those policies that have the most significant impact on Max Life’s consolidated financial statements and require management to use a greater degree of judgment and estimates. Actual results may differ from those estimates.
 
 
-10-


 
Our management believes that given current facts and circumstances, it is unlikely that applying any other reasonable judgments or estimate methodologies would cause effect on our consolidated results of operations, financial position or liquidity for the periods presented in this report.

The Company believes that the following discussion addresses the Company’s most critical accounting policies, which are those that are most important to the portrayal of the Company’s financial condition and results of operations and require management’s most difficult, subjective and complex judgments.

Investment in Life Insurance Policies
 
Investment in life insurance policies are recorded in accordance with ASC 325-30, Investments in Insurance Contracts.  Under ASC 325-30 an investor may elect to account for its investments in life settlement contracts using either the investment method or the fair value method.  The election shall be made on an instrument by instrument basis and is irrevocable.  Under the investment method, an investor shall recognize the initial investment at the purchase price plus all initial direct costs.  Continuing costs (policy premiums and direct external costs, if any) to keep the policy in force shall be capitalized.  Under the fair value method, an investor shall recognize the initial investment at the purchase price.  In subsequent periods, the investor shall remeasure the investment at fair value in its entirety at each reporting period and shall recognize change in fair value earnings (or other performance indicators for entities that do not report earnings) in the period in which the changes occur.  The Company has elected to value its investments in life settlement contracts using the investment method.
 
Stock Based Compensation
 
ASC 718 – Stock Compensation establishes standards for the accounting for transaction in which an entity exchanges its equity instruments for goods for services. It also addresses transactions in which an entity incurs liabilities in exchange for goods or services that are based on the fair value of the entity’s equity instruments or that may be settled by the issuance of those equity instruments. ASC 718 – Stock Compensation focuses primarily on accounting for transactions in which an entity obtains employee services in shared-based payment transactions. ASC 718 – Stock Compensation requires that the compensation cost relating to share-based payment transactions be recognized in the consolidated financial statements. That cost will be measured based on the fair value of the equity or liability instruments issued.

We cannot predict what future laws and regulations might be passed that could have a material effect on our results of operations. We assess the impact of significant changes in laws and regulations on a regular basis and update the assumptions and estimates used to prepare our financial statements when we deem it necessary.

We have not made any material changes to our critical accounting estimates or assumptions or the judgments affecting the application of those estimates or assumptions. We discuss our significant accounting policies, including those policies that are not critical, in our Consolidated Financial Statements.
 
Off-Balance Sheet Arrangements
 
We do not have any outstanding derivative financial instruments, off-balance sheet guarantees, interest rate swap transactions or foreign currency contracts. We do not engage in trading activities involving non-exchange traded contracts.

Item 3. Quantitative and Qualitative Disclosures About Market Risk.

The Company is subject to certain market risks, including changes in interest rates and currency exchange rates.  The Company does not undertake any specific actions to limit those exposures.
 
 
-11-

 
Item 4T.  Controls and Procedures.

Evaluation of disclosure controls and procedures

Under the supervision and with the participation of our management, including our President, Chief Executive Officer, Chief Financial Officer, Principal Accounting Officer and Director (the “Certifying Officer”) we evaluated the effectiveness of the design and operation of our disclosure controls and procedures (as defined in Rules 13a-15(e) under the Securities Exchange Act of 1934 (the “Exchange Act”). Based upon that evaluation, the Certifying Officer concluded that, as of the end of the period covered by this report, our disclosure controls and procedures were not effective. We and our auditors identified material weaknesses discussed below in the Report of management on internal control over financial reporting.

Report of Management on Internal Control over Financial Reporting

Our management is responsible for establishing and maintaining adequate internal control over financial reporting as defined in Rules 13a-15(f) under the Exchange Act. Our internal control over financial reporting is designed to provide reasonable assurance regarding the reliability of financial reporting and the preparation of financial statements for external purposes in accordance with U.S. generally accepted accounting principles. Our internal control over financial reporting includes those policies and procedures that:

(i)  
pertain to the maintenance of records that, in reasonable detail, accurately and fairly reflect the transactions and dispositions of our assets;

(ii)  
provide reasonable assurance that transactions are recorded as necessary to permit preparation of financial statements in accordance with U.S. generally accepted accounting principles, and that our receipts and expenditures are being made only in accordance with authorizations of our management and directors; and

(iii)  
provide reasonable assurance regarding prevention or timely detection of unauthorized acquisition, use or disposition of assets that could have a material effect on the financial statements.

Because of its inherent limitations, internal control over financial reporting may not prevent or detect misstatements. Also, projections of any evaluation of effectiveness to future periods are subject to the risk that controls may become inadequate because of changes in conditions or that the degree of compliance with the policies or procedures may deteriorate.

Management conducted an evaluation of the effectiveness of our internal control over financial reporting based on the framework in Internal Control – Integrated Framework issued by the Committee of Sponsoring Organizations of the Treadway Commission. A material weakness is a deficiency, or a combination of deficiencies, in internal control over financial reporting, such that there is a reasonable possibility that a material misstatement to the Company’s annual or interim financial statements will not be prevented or detected.

In the course of management’s assessment, we have identified the following material weaknesses in internal control over financial reporting:

·  
Segregation of Duties – As a result of limited resources, we did not maintain proper segregation of incompatible duties. Namely the lack of an audit committee, an understaffed financial and accounting function, and the need for additional personnel to prepare and analyze financial information in a timely manner and to allow review and on-going monitoring and enhancement of our controls. The effect of the lack of segregation of duties potentially affects multiple processes and procedures.

·  
Maintenance of Current Accounting Records – This weakness specifically affects the payments and purchase cycle and therefore we failed to maintain effective internal controls over the completeness and cut off of accounts payable, expenses and other capital transactions.

·  
Application of GAAP – We did not maintain effective internal controls relating to the application of generally accepted accounting principles in accounting for transactions in a foreign currency.

We are in the continuous process of improving our internal control over financial reporting in an effort to eliminate these material weaknesses through improved supervision and training of our staff, but additional effort is needed to fully remedy these deficiencies. Management has engaged a Certified Public Accountant as a consultant to assist with the financial reporting process in an effort to mitigate some of the identified weaknesses. The Company is still in its development stage and intends on hiring the necessary staff to address the weaknesses once full operations have commenced.

Because of its inherent limitations, internal control over financial reporting may not prevent or detect misstatements.  Therefore, even those systems determined to be effective can provide only reasonable assurance with respect to financial statement preparation and presentation.
 
 
-12-

 
 
PART II - OTHER INFORMATION
 
Item 1.   Legal Proceedings.
 
We are currently not involved in any litigation that we believe could have a material adverse effect on our financial condition or results of operations. There is no action, suit, proceeding, inquiry or investigation before or by any court, public board, government agency, self-regulatory organization or body pending or, to the knowledge of the executive officers of our company or any of our subsidiaries, threatened against or affecting our company, our common stock, any of our subsidiaries or of our companies or our subsidiaries’ officers or directors in their capacities as such, in which an adverse decision could have a material adverse effect.

Item 1A. Risk Factors.

We believe there are no changes that constitute material changes from the risk factors previously disclosed in our Annual Report on Form 10-K for the year ended August 31, 2009, filed with the SEC on November 30, 2009.

Item 2.   Unregistered Sales of Equity Securities and Use of Proceeds.
 
None.
 
Item 3.   Defaults Upon Senior Securities.
 
None.
 
Item 4.   (Removed and Reserved).
  
Item 5.   Other Information.
 
None.
 
Item 6.   Exhibits.
 
Exhibit No.     Description
 
31.1                 Certification of Chief Executive Officer pursuant to Section 302 of Sarbanes Oxley Act of 2002

31.2                 Certification of Chief Financial Officer pursuant to Section 302 of Sarbanes Oxley Act of 2002
 
32.1                 Certification of Chief Executive Officer pursuant to Section 906 of Sarbanes Oxley Act of 2002

32.2                 Certification of Chief Financial Officer pursuant to Section 906 of Sarbanes Oxley Act of 2002
 

-13-

 
 
SIGNATURES
 
Pursuant to the requirements of the Securities Exchange Act of 1934, as amended, the registrant caused this report to be signed on its behalf by the undersigned, thereunto duly authorized.



 
MAXLIFE FUND CORP.
   
April 9, 2010
 
 
/s/ Bennett Kurtz
 
Bennett Kurtz
Chief Executive Officer
Chief Financial Officer
 
 
 
 
 -14-

 

 
EX-31.1 2 f10q0210ex31i_maxlife.htm CERTIFICATION PURSUANT TO SECTION 302 OF SARBANES OXLEY ACT OF 2002 f10q0210ex31i_maxlife.htm
 
Exhibit 31.1
 
CERTIFICATION OF CHIEF EXECUTIVE OFFICER
PURSUANT TO
18 U.S.C. SECTION 1350,
AS ADOPTED PURSUANT TO SECTION 302 OF
THE SARBANES-OXLEY ACT OF 2002
 
I, Bennett Kurtz, certify that:
 
1.
I have reviewed this Form 10-Q of Maxlife Fund Corp.;
 
2.
Based on my knowledge, this report does not contain any untrue statement of a material fact or omit to state a material fact necessary to make the statements made, in light of the circumstances under which such statements were made, not misleading with respect to the period covered by this report;
 
3.
Based on my knowledge, the financial statements, and other financial information included in this report, fairly present in all material respects the financial condition, results of operations and cash flows of the registrant as of, and for, the periods present in this report;
 
4.
I am responsible for establishing and maintaining disclosure controls and procedures (as defined in Exchange Act Rules 13a-15(e) and 15d-15(e)) and internal control over financial reporting (as defined in Exchange Act Rules 13-a-15(f) and 15d-15(f)) for the registrant and have:
 
 
a)
Designed such disclosure controls and procedures, or caused such disclosure controls and procedures to be designed under our supervision, to ensure that material information relating to the registrant, including its consolidated subsidiaries, is made known to us by others within those entities, particularly during the period in which this report is being prepared;
 
 
b)
Designed such internal control over financial reporting, or caused such internal control over financial reporting to be designed under our supervision, to provide reasonable assurance regarding the reliability of financial reporting and the preparation of financial statements for external purposes in accordance with generally accepted accounting principles;
 
 
c)
Evaluated the effectiveness of the registrant’s disclosure controls and procedures and presented in this report our conclusions about the effectiveness of the disclosure controls and procedures, as of the end of the period covered by this report based on such evaluation; and
 
 
d)
Disclosed in this report any change in the registrant’s internal control over financing reporting that occurred during the registrant’s most recent fiscal quarter (the registrant’s fourth fiscal quarter in the case of an annual report) that has materially affected, or is reasonably likely to materially affect, the registrant’s internal control over financial reporting; and
 
5.
I have disclosed, based on our most recent evaluation of internal control over financial reporting, to the registrant’s auditors and the audit committee of the registrant’s board of directors (or persons performing the equivalent functions):
 
 
a)
All significant deficiencies and material weaknesses in the design or operation of internal control over financial reporting which are reasonably likely to adversely affect the registrant’s ability to record, process, summarize and report financial information; and
 
 
b)
Any fraud, whether or not material, that involved management or other employees who have a significant role in the registrant’s internal control over financial reporting.

       
Date: April 9, 2010      
By:
/s/ Bennett Kurtz       
 
   
Bennett Kurtz
 
   
Chief Executive Officer
 
 
 
EX-31.2 3 f10q0210ex31ii_maxlife.htm CERTIFICATION PURSUANT TO SECTION 302 OF SARBANES OXLEY ACT OF 2002 f10q0210ex31ii_maxlife.htm
 
Exhibit 31.2
 
CERTIFICATION OF CHIEF FINANCIAL OFFICER
PURSUANT TO
18 U.S.C. SECTION 1350,
AS ADOPTED PURSUANT TO SECTION 302 OF
THE SARBANES-OXLEY ACT OF 2002
 
I, Bennett Kurtz, certify that:
 
1.
I have reviewed this Form 10-Q of Maxlife Fund Corp.;
 
2.
Based on my knowledge, this report does not contain any untrue statement of a material fact or omit to state a material fact necessary to make the statements made, in light of the circumstances under which such statements were made, not misleading with respect to the period covered by this report;
 
3.
Based on my knowledge, the financial statements, and other financial information included in this report, fairly present in all material respects the financial condition, results of operations and cash flows of the registrant as of, and for, the periods present in this report;
 
4.
I am responsible for establishing and maintaining disclosure controls and procedures (as defined in Exchange Act Rules 13a-15(e) and 15d-15(e)) and internal control over financial reporting (as defined in Exchange Act Rules 13-a-15(f) and 15d-15(f)) for the registrant and have:
 
 
a)
Designed such disclosure controls and procedures, or caused such disclosure controls and procedures to be designed under our supervision, to ensure that material information relating to the registrant, including its consolidated subsidiaries, is made known to us by others within those entities, particularly during the period in which this report is being prepared;
 
 
b)
Designed such internal control over financial reporting, or caused such internal control over financial reporting to be designed under our supervision, to provide reasonable assurance regarding the reliability of financial reporting and the preparation of financial statements for external purposes in accordance with generally accepted accounting principles;
 
 
c)
Evaluated the effectiveness of the registrant’s disclosure controls and procedures and presented in this report our conclusions about the effectiveness of the disclosure controls and procedures, as of the end of the period covered by this report based on such evaluation; and
 
 
d)
Disclosed in this report any change in the registrant’s internal control over financing reporting that occurred during the registrant’s most recent fiscal quarter (the registrant’s fourth fiscal quarter in the case of an annual report) that has materially affected, or is reasonably likely to materially affect, the registrant’s internal control over financial reporting; and
 
5.
I have disclosed, based on our most recent evaluation of internal control over financial reporting, to the registrant’s auditors and the audit committee of the registrant’s board of directors (or persons performing the equivalent functions):
 
 
a)
All significant deficiencies and material weaknesses in the design or operation of internal control over financial reporting which are reasonably likely to adversely affect the registrant’s ability to record, process, summarize and report financial information; and
 
 
b)
Any fraud, whether or not material, that involved management or other employees who have a significant role in the registrant’s internal control over financial reporting.

       
Date: April 9, 2010  
By:
/s/ Bennett Kurtz
 
   
Bennett Kurtz
 
   
Chief Financial Officer
 
EX-32.1 4 f10q0210ex32i_maxlife.htm CERTIFICATION PURSUANT TO SECTION 906 OF SARBANES OXLEY ACT OF 2002 f10q0210ex32i_maxlife.htm
 
Exhibit 32.1
 
CERTIFICATION PURSUANT TO
18 U.S.C. SECTION 1350,
AS ADOPTED PURSUANT TO SECTION 906 OF
THE SARBANES-OXLEY ACT OF 2002
 
 
In connection with this Quarterly Report of Maxlife Fund Corp. (the “Company”) on Form 10-Q for the period ending February 28, 2010, as filed with the Securities and Exchange Commission on the date hereof (the “Report”), I, Bennett Kurtz, Chief Executive Officer of the Company, certify to the best of my knowledge, pursuant to 18 U.S.C. Sec. 1350, as adopted pursuant to Sec. 906 of the Sarbanes-Oxley Act of 2002, that:

(1)  
Such Quarterly Report on Form 10-Q for the period ending February 28, 2009, fully complies with the requirements of section 13(a) or 15(d) of the Securities Exchange Act of 1934; and

(2)  
The information contained in such Quarterly Report on Form 10-Q for the period ending February 28, 2010, fairly presents, in all material respects, the financial condition and results of operations of Maxlife Fund Corp.
   
 
Date: April 9, 2010    
By:
/s/ Bennett Kurtz
 
   
Bennett Kurtz
 
   
Chief Executive Officer
 
 


 
 
EX-32.2 5 f10q0210ex32ii_maxlife.htm CERTIFICATION PURSUANT TO SECTION 906 OF SARBANES OXLEY ACT OF 2002 f10q0210ex32ii_maxlife.htm
 
Exhibit 32.2
 
 
CERTIFICATION PURSUANT TO
18 U.S.C. SECTION 1350,
AS ADOPTED PURSUANT TO SECTION 906 OF
THE SARBANES-OXLEY ACT OF 2002
 
 
In connection with this Quarterly Report of Maxlife Fund Corp. (the “Company”) on Form 10-Q for the period ending February 28, 2010, as filed with the Securities and Exchange Commission on the date hereof (the “Report”), I, Bennett Kurtz, Chief Financial Officer of the Company, certify to the best of my knowledge, pursuant to 18 U.S.C. Sec. 1350, as adopted pursuant to Sec. 906 of the Sarbanes-Oxley Act of 2002, that:

(1)  
Such Quarterly Report on Form 10-Q for the period ending February 28, 2009, fully complies with the requirements of section 13(a) or 15(d) of the Securities Exchange Act of 1934; and

(2)  
The information contained in such Quarterly Report on Form 10-Q for the period ending February 28, 2010, fairly presents, in all material respects, the financial condition and results of operations of Maxlife Fund Corp.
   
 
Date: April 9, 2010    
By:
/s/ Bennett Kurtz
 
   
Bennett Kurtz
 
   
Chief Financial Officer
 
 

 
-----END PRIVACY-ENHANCED MESSAGE-----